Cosmetic Claim Substantiation: What OEM Brands Need to Know Before Going to Market

The claims printed on your product's packaging and used in your marketing are more than descriptive text — they are regulatory commitments. In both the EU and the US, cosmetic product claims must be substantiated by evidence, and the consequences of unsubstantiated or misleading claims range from advertising challenges and retailer delisting to regulatory enforcement and brand reputational damage.

This guide explains the claim substantiation framework for cosmetic products, the types of evidence that support different claim categories, and how your OEM manufacturer should be contributing to the evidence-building process.

The Regulatory Framework: EU and US Requirements

In the European Union, Regulation (EC) No 1223/2009 on cosmetic products and its associated Common Criteria for claims (Regulation (EU) No 655/2013) establish six principles that all cosmetic claims must satisfy: legal compliance, truthfulness, evidential support, honesty, fairness, and informed decision-making. The evidential support requirement is explicit: claims must be supported by adequate and verifiable evidence, and that evidence must be held in the Product Information File (PIF).

In the United States, the FTC Act prohibits unfair or deceptive acts or practices, which includes advertising claims that are not substantiated by competent and reliable scientific evidence. The FDA additionally regulates the boundary between cosmetic and drug claims — a distinction that has significant implications for how efficacy claims are worded.

Both frameworks share a common principle: the burden of proof lies with the brand, not the regulator. You must have the evidence before you make the claim, not after a challenge is received.

Types of Claim Substantiation Evidence

Consumer Perception Studies

The most commonly used and cost-effective form of claim substantiation for cosmetic products. A panel of consumers (typically 20–50 participants) uses the product for a defined period (usually 4–8 weeks) and self-assesses changes in skin appearance and texture using validated questionnaire instruments. Results are expressed as percentage agreement: "X% of participants agreed their skin felt more hydrated after 4 weeks."

Consumer perception studies support claims that reference how skin looks or feels — "skin appears smoother," "skin feels more hydrated," "visibly reduces the appearance of fine lines." They do not support mechanistic claims ("stimulates collagen production") or quantified clinical claims ("reduces wrinkle depth by 30%").

Instrument-Based Measurements

Objective skin measurement instruments provide quantitative data that supports more specific claims. Common instruments and their applications include: Corneometer (skin hydration), Tewameter (skin barrier function/TEWL), Cutometer (skin elasticity and firmness), Mexameter/Colorimeter (skin tone, pigmentation, redness), Primos/Visioscan (skin texture and wrinkle depth).

Instrument-based studies are typically conducted alongside consumer perception studies to provide both objective measurement and subjective experience data. They support claims that reference specific skin parameters: "improves skin elasticity," "reduces transepidermal water loss," "visibly evens skin tone."

In-Vitro Testing

Cell-based or model-based laboratory tests that assess the activity of a formula or ingredient against specific biological targets. Common in-vitro assays for cosmetic claim support include: collagen synthesis assays (for anti-aging claims), melanogenesis inhibition assays (for brightening claims), antioxidant capacity assays (for antioxidant claims), and skin barrier model studies.

In-vitro data supports mechanistic claims when appropriately qualified: "formulated with ingredients shown in laboratory testing to support collagen synthesis" is supportable by in-vitro data; "clinically proven to stimulate collagen production" is not.

Controlled Clinical Studies

The gold standard for efficacy claim substantiation. A controlled clinical study involves a defined protocol, randomized allocation, blinded assessment, and statistical analysis of results. Clinical studies support the strongest efficacy claims: "clinically proven to reduce wrinkle depth by X% in Y weeks," "dermatologist-tested and proven effective for sensitive skin," or specific comparative claims.

Controlled clinical studies are more expensive ($10,000–$60,000+ depending on design complexity, panel size, duration, and measurements) and take longer to complete (12–24 weeks is common for anti-aging studies). For brands entering the premium or professional skincare segment, the investment is typically justified by the marketing differentiation and retailer credibility the evidence provides.

A common mistake: using ingredient supplier clinical data to make finished product claims. If the supplier has a study showing their hyaluronic acid ingredient improves skin hydration, you can reference the ingredient's properties. But you cannot claim the study proves your finished product works — your finished product must generate its own evidence.

Matching Evidence Level to Claim Strength

Claim Type	Minimum Evidence Required	Notes
"Hydrating formula" / "moisturising"	Consumer perception or corneometer study	Standard claims; straightforward to substantiate
"Tested by dermatologists"	Dermatologist evaluation protocol	Protocol and evaluator credentials must be documented
"Reduces the appearance of wrinkles"	Consumer perception + instrument measurement	"Appearance" qualifier reduces evidence threshold
"Clinically proven to reduce wrinkles by X%"	Controlled clinical study	Requires full study protocol and statistical significance
"Brightens skin tone"	Consumer perception + colorimeter or mexameter	Before/after photography can supplement
"Repairs skin barrier"	TEWL measurement (Tewameter study)	Mechanistic claims require objective measurement
"Anti-aging" (general)	Consumer perception study	General claims require less evidence than specific quantified claims

How Your OEM Manufacturer Should Support Claim Substantiation

A capable OEM manufacturer contributes to your claim substantiation process in several ways:

Ingredient documentation: Providing verified ingredient supplier data, COAs, and published literature supporting the mechanism of action of key actives in your formula.

In-vitro testing coordination: Partnering with accredited testing laboratories to conduct cell-based or model-based activity assays on your finished formula.

Clinical testing referrals: Facilitating introductions to qualified independent clinical research organizations (CROs) for consumer perception studies or controlled clinical trials.

HPLC active assay: Providing quantitative confirmation of active ingredient concentration in the finished product, enabling claims that reference specific active levels.

Historical formula data: For ODM products based on validated formulas, providing any existing efficacy data from previous studies on the same or similar formulations.

Claims That Trigger Drug Classification: The Risk to Avoid

In the US, any cosmetic product claim that attributes a physiological effect — altering the body's structure or function — moves the product into drug territory requiring FDA approval. Examples of claims that have triggered drug classification enforcement include: "stimulates collagen production," "accelerates cell turnover," "treats wrinkles," "prevents hair loss," "treats acne." The safe cosmetic equivalents reference appearance rather than function: "visibly reduces the appearance of fine lines," "skin looks smoother and more even," "helps maintain hair density." Your OEM manufacturer should flag any proposed claims that approach this boundary and recommend compliant alternative language.

Conclusion

Claim substantiation is not bureaucracy — it is the foundation of honest marketing and a practical risk management tool in a regulatory environment that is increasingly scrutinizing cosmetic brand communication. Brands that invest in evidence for their claims build more defensible marketing positions, achieve greater credibility with premium retailers, and are better protected against regulatory challenge.

Building the evidence strategy into your OEM product development process — rather than adding it as an afterthought before launch — produces better evidence at lower cost and gives your formulation team the opportunity to optimize the formula for the specific claims you want to make. SEYE's team works with clients on this integrated approach. Contact SEYE to discuss how we can support your next product launch from formula to claim.